These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 492252)
41. Multiple accessory pathways in the Wolff-Parkinson-White syndrome as a risk factor for ventricular fibrillation. Teo WS; Klein GJ; Guiraudon GM; Yee R; Leitch JW; McLellan D; Leather RA; Kim YH Am J Cardiol; 1991 Apr; 67(9):889-91. PubMed ID: 2011990 [No Abstract] [Full Text] [Related]
42. Atrial fibrillation with wide QRS tachycardia and undiagnosed Wolff-Parkinson-White syndrome: diagnostic and therapeutic dilemmas in a pediatric patient. Panduranga P; Al-Farqani A; Al-Rawahi N Pediatr Emerg Care; 2012 Nov; 28(11):1227-9. PubMed ID: 23128652 [TBL] [Abstract][Full Text] [Related]
43. Electrophysiological features of orthodromic atrioventricular reentry tachycardia in patients with wolff-Parkinson-white syndrome and atrial fibrillation. Kalarus Z; Kowalski O; Lenarczyk R; Prokopczuk J; Pasyk S Pacing Clin Electrophysiol; 2003 Jul; 26(7 Pt 1):1479-88. PubMed ID: 12914625 [TBL] [Abstract][Full Text] [Related]
44. [Ventricular pre-excitation in Wolff Parkinson White syndrome in the aged]. Tamburrini LR; Fontanelli A; Bizzarini E; Faggioli F Minerva Cardioangiol; 1998 Dec; 46(12):493-506. PubMed ID: 10209940 [TBL] [Abstract][Full Text] [Related]
45. Functional properties of accessory atrioventricular pathways in Wolff-Parkinson-White syndrome. Clinical implications. German LD; Gallagher JJ Am J Med; 1984 Jun; 76(6):1079-86. PubMed ID: 6731464 [TBL] [Abstract][Full Text] [Related]
46. Transesophageal versus intracardiac atrial stimulation in assessing anterograde conduction properties of the accessory pathway in Wolff-Parkinson-White syndrome. Favale S; Minafra F; Massari V; Tritto M; Rizzon P Int J Cardiol; 1991 Feb; 30(2):209-14. PubMed ID: 2010244 [TBL] [Abstract][Full Text] [Related]
47. Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome. Kerr CR; Prystowsky EN; Smith WM; Cook L; Gallagher JJ Circulation; 1982 May; 65(5):869-78. PubMed ID: 6804107 [TBL] [Abstract][Full Text] [Related]
48. Atrial fibrillation in the preexcitation syndrome. Campbell RW; Smith RA; Gallagher JJ; Pritchett EL; Wallace AG Am J Cardiol; 1977 Oct; 40(4):514-20. PubMed ID: 910715 [TBL] [Abstract][Full Text] [Related]
49. Relation of the utility of exercise testing for risk assessment in pediatric patients with ventricular preexcitation to pathway location. Spar DS; Silver ES; Hordof AJ; Liberman L Am J Cardiol; 2012 Apr; 109(7):1011-4. PubMed ID: 22221954 [TBL] [Abstract][Full Text] [Related]
50. Electrophysiologic effects of lorcainide on the accessory pathway in the Wolff-Parkinson-White syndrome. Kasper W; Treese N; Meinertz T; Jähnchen E; Pop T Am J Cardiol; 1983 Jun; 51(10):1618-22. PubMed ID: 6858867 [TBL] [Abstract][Full Text] [Related]
51. Atrial and ventricular vulnerability in a patient with the Wolff-Parkinson-White syndrome. Peters RW; Gonzalez R; Scheinman MM Pacing Clin Electrophysiol; 1981 Jan; 4(1):17-22. PubMed ID: 6171787 [TBL] [Abstract][Full Text] [Related]
52. Idiopathic ventricular fibrillation in a patient with Wolff-Parkinson-White syndrome. Kose S; Barcin C; Iyisoy A; Kursaklioglu H; Isik E; Demirtas E Jpn Heart J; 2002 May; 43(3):283-7. PubMed ID: 12227703 [TBL] [Abstract][Full Text] [Related]
53. Electrophysiologic testing in the management of patients with the Wolff-Parkinson-White syndrome and atrial fibrillation. Morady F; Sledge C; Shen E; Sung RJ; Gonzales R; Scheinman MM Am J Cardiol; 1983 Jun; 51(10):1623-8. PubMed ID: 6858868 [TBL] [Abstract][Full Text] [Related]
54. Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients. Pappone C; Vicedomini G; Manguso F; Saviano M; Baldi M; Pappone A; Ciaccio C; Giannelli L; Ionescu B; Petretta A; Vitale R; Cuko A; Calovic Z; Fundaliotis A; Moscatiello M; Tavazzi L; Santinelli V Circulation; 2014 Sep; 130(10):811-9. PubMed ID: 25052405 [TBL] [Abstract][Full Text] [Related]
55. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation. Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013 [TBL] [Abstract][Full Text] [Related]
56. Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome. Feld GK; Nademanee K; Stevenson W; Weiss J; Klitzner T; Singh BN Am Heart J; 1988 Jan; 115(1 Pt 1):102-7. PubMed ID: 3336964 [TBL] [Abstract][Full Text] [Related]
57. Nonclinical ventricular tachycardia in the Wolff-Parkinson-White syndrome. Milstein S; Sharma AD; Klein GJ Pacing Clin Electrophysiol; 1985 Sep; 8(5):678-83. PubMed ID: 2414749 [TBL] [Abstract][Full Text] [Related]
58. New observations on atrial fibrillation before and after surgical treatment in patients with the Wolff-Parkinson-White syndrome. Chen PS; Pressley JC; Tang AS; Packer DL; Gallagher JJ; Prystowsky EN J Am Coll Cardiol; 1992 Apr; 19(5):974-81. PubMed ID: 1552122 [TBL] [Abstract][Full Text] [Related]
59. Preexcited reciprocating tachycardia in patients with Wolff-Parkinson-White syndrome: incidence and mechanisms. Bardy GH; Packer DL; German LD; Gallagher JJ Circulation; 1984 Sep; 70(3):377-91. PubMed ID: 6744541 [TBL] [Abstract][Full Text] [Related]
60. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome. Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]